antibody technologyTo this end, arGEN-X has invented and developed a breakthrough discovery platform setting the new standard for antibody lead choice in the discovery of human antibody therapeutics. Fuelled by the best possible natural immune responses available,...
Total money raised: $62M
HQ3015 Dr Molewaterplein 50
Phone: +31 (0)10 70 38 441
arGEN-X at CrunchBase
arGEN-X raised $43.9M in a Series B round from OrbiMed Advisors, Forbion Capital Partners, Crédit Agricole Private Equity, LSP BioVentures, Erasmus MC Biomedical Fund, Seventure Partners, and PMV-Vinnof
arGEN-X raised $4.5M in a Series A round from Crédit Agricole Private Equity, Forbion Capital Partners, Life Sciences Partners, KBC, BioGeneration Ventures, Erasmus MC Biomedical Fund, and Thuja Capital